Phase 2 Hypoglycaemia Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Not Yet Recruiting
Phase 2
Insulin-dextrose vs glucose-only therapy for the treatment of hyperkalaemia
HyperkalaemiaHypoglycaemia
University of Queensland95 enrolled1 locationACTRN12625000617460
Completed
Phase 2Phase 3
Diazoxide for babies with severe or recurrent low blood glucose: The Neonatal Glucose Care Optimisation (NeoGluCO) Study
Neonatal hypoglycaemia
Liggins Institute, University of Auckland74 enrolled1 locationACTRN12620000129987
Recruiting
Phase 2
A multi-centre trial of a new immunosuppression regime for pancreatic islet transplant recipients
Hypoglycaemia UnawarenessIslet graft survivalType 1 Diabetes
The University of Sydney15 enrolled3 locationsACTRN12619000268145
Completed
Phase 2Phase 3
In clinic evaluation of an "artificial pancreas" for the management of type 1 diabetes, when possible hypoglycaemia causing scenarios are simulated.
Hypoglycaemia
Dr Martin de Bock8 enrolled1 locationACTRN12614001005640
Recruiting
Phase 2
The effects of Glucagon-Like Peptide 1 on gastric emptying in healthy volunteers with normal or low blood glucose levels
Gastric emptying in the context of supraphysiologic Glucagon-Like Peptide-1 and hypoglycaemia
Dr Mark Plummer10 enrolled1 locationACTRN12611000973910